sanofi, glaxosmithkline reach $2.1 billion deal with u.s. to supply vaccine doses
Published 3 years ago • 39K plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:48
gsk on $2.1b vaccine supply deal with u.s.
-
4:24
jim cramer on sanofi & gsk partnership on coronavirus vaccine
-
10:48
coronavirus: glaxoklinesmith ceo talks 'unprecedented collaboration' with sanofi on vaccine
-
1:00
coronavirus: glaxosmithkline ceo on developing an 'adjuvant vaccine against covid-19'
-
6:04
sanofi ceo on two-pronged approach to developing covid-19 vaccine
-
4:33
what sars-cov-2 variant will be in 2024-2025 covid-19 vaccines?
-
28:16
covid-19 long haulers - first choice neurology - jeffrey gelblum, md
-
9:23
how corning's gorilla glass tech helped deliver covid vaccines
-
2:13
sanofi halts development of its covid mrna vaccine
-
3:20
sanofi to manufacture up to 200m doses of moderna's covid vaccine
-
1:22
drug giants gsk and sanofi to supply 60-m doses of coronavirus vaccines in the uk
-
1:36
sanofi ceo on coronavirus vaccine development and the pressure 'to get it right'
-
2:35
covid vaccine by sanofi-gsk delayed after disappointing results in older patients
-
12:17
glaxo joins forces with sanofi to develop coronavirus vaccine
-
1:51
sanofi's first quarter boosted by eczema treatment and vaccines
-
4:54
coronavirus: sanofi ceo explains its multi-pronged effort to treat and test for covid-19
-
1:21
u.s. to pay sanofi, gsk $2.1 bln for vaccines
-
2:05
glaxosmithkline and vir start phase 2/3 study for covid-19 antibody drug
-
0:45
u.s. likely to get sanofi's covid-19 vaccine first if it succeeds
-
3:04
sanofi to help produce doses of pfizer-biontech covid vaccine
-
2:31
sanofi and gsk see positive interim results for their covid vaccine in trials
-
4:32
sanofi: our vaccine could serve as an excellent booster shot